Steven Sowa

Q: What is Steven Sowa email address?

Email Steven Sowa at steven.sowa@bms.com. This email is the most updated Steven Sowa email found in 2026.

Q: How to contact Steven Sowa?

To contact Steven Sowa send an email to steven.sowa@bms.com. If you want to call Steven Sowa try calling on +18604361990.

Senior Principal Scientist at Bristol Myers Squibb | Greater Boston

About Steven Sowa

Steven Sowa serves as a Senior Principal Scientist at Bristol Myers Squibb, where he leads the Microbial Upstream Process Development Group. In this pivotal role, Steven manages a dedicated team of three full-time employees, overseeing more than five active microbial projects that are critical to the development of biologic products. His expertise spans a diverse range of topics, including the development of innovative tools for determining RNA structures and in-depth studies on bacterial small RNAs. Currently, he focuses on drug process development, where he applies his extensive knowledge in protein purification and production process development to create robust strategies for biologic manufacturing.

Steven's work involves the development of processes for various biologic products, including small proteins, plasmid DNA, and antibodies. He is instrumental in supporting technology transfer to both internal and external manufacturing sites, ensuring that processes are scalable and efficient. His proficiency in running processes on multiple scales, including Ambr systems, allows for the optimization of production workflows and enhances the overall quality of the biologics produced.

With a strong foundation in data analysis and transcriptomics, Steven leverages advanced tools like gPROMS to model and optimize microbial processes. His commitment to continuous learning and teaching further enriches his team's capabilities, fostering an environment of innovation and collaboration. Through his leadership and technical expertise, Steven Sowa is making significant contributions to the advancement of biologic drug development at Bristol Myers Squibb, ultimately aiming to improve patient outcomes through the delivery of high-quality therapeutics.

Steven Sowa Work